Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | DBH | P09172 | 1/20 | 0.39 |
| ▸ | PTPRS | Q13332 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | IDH1 | O75874 | 1/20 | 0.32 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7712387 | 1.00 | — | — | |
| SCHEMBL588597 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL22711054 | 0.95 | MMP2 (0.50) | MMP2DBHPTPRSKDM4ELMNA | |
| SCHEMBL10489061 | 0.95 | — | — | |
| SCHEMBL6021918 | 0.95 | — | — | |
| Maltol SCHEMBL6666789 | 0.79 | KDM4E (0.72) | MMP2PTPRSKDM4ELMNAAPP | |
| SCHEMBL8143882 | 0.74 | KDM4E (0.42) | MMP2KDM4ELMNATYRAPP | |
| SCHEMBL11091048 | 0.67 | — | — | |
| SCHEMBL2241092 | 0.67 | — | — | |
| SCHEMBL10843892 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0833627-B1 | IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF | VITRA PHARMACEUTICALS LTD (GB) | 2004-08-18 | — | — | EP | disclosed |
| US-6635631-B2 | Ferric iron complex of a hydroxypyrone ligand and a carboxylic acid; used to treat iron deficiency anemia | VITRA PHARMACEUTICALS, LTD. (GB) | 2003-10-21 | — | — | US | disclosed |
| US-20030069218-A1 | Iron compounds, compositions , methods of making the same and uses thereof | IRON THERAPEUTICS HOLDINGS AG (CH) | 2003-04-10 | — | — | US | disclosed |
| US-6339080-B1 | FOR THERAPY AND PROPHYLAXIS OF IRON DEFICIENCY DISORDERS INCLUDING IRON DEFICIENCY ANAEMIA | VITRA PHARMACEUTICALS LTD. (GB) | 2002-01-15 | — | — | US | disclosed |
| EP-0833627-A2 | IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF | Vitra Pharmaceuticals Ltd. (GB) | 1998-04-08 | — | — | EP | disclosed |
| WO-1996041627-A2 | IRON COMPOUNDS, COMPOSITIONS, METHODS OF MAKING THE SAME AND USES THEREOF | VITRA PHARMACEUTICALS LTD (GB) | 1996-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069218-A1 | Iron compounds, compositions , methods of making the same and uses thereof | SDHB, HAMP, FTH1 | MMP2 2692/4885DBH 851/4885PTPRS 2065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.